Page last updated: 2024-08-16

ribavirin and Heart Defects, Congenital

ribavirin has been researched along with Heart Defects, Congenital in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (8.33)	18.7374
1990's	9 (75.00)	18.2507
2000's	1 (8.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (8.33)	2.80

Authors

Authors	Studies
Bao, Z; Cai, B; Gao, X; Han, Z; Hua, B; Huang, Q; Li, Y; Liu, S; Ma, T; Ma, W; Wang, X; Xu, Y; Xu, Z; Yan, G; Yang, F; Ye, D; Yu, Y; Yuan, Y; Zhang, L	1
Chen, CH; Chiang, BL; Kao, CL; Lee, JH; Lin, YT; Wang, LC; Yang, YH	1
DeVincenzo, J	1
Custer, JR; Khan, AS; Meliones, JN; Moler, FW; Palmisano, J; Shope, TC	1
Ajizian, SJ; Mitchell, I; Newth, CJ; Stretton, M	1
Begue, RE; Dennehy, PH	1
Groothuis, JR; Hall, CB; Katz, R; Lauer, BA; McBride, JT; McWilliams, BC; Robertson, AD; Woodin, KA	1
Edelson, PJ	1
Lauer, B	1
Eisenberg, J	1
Brown, JC; Colombo, JL; Gumbiner, CH; Kugler, JD; Martin, JT; McManus, BM; Murphy, KR	1
Gala, CL; Hall, CB; Hildreth, SW; McBride, JT; Schnabel, KC	1

Reviews

1 review(s) available for ribavirin and Heart Defects, Congenital

Article	Year
Prevention and treatment of respiratory syncytial virus infections (for advances in pediatric infectious diseases). Advances in pediatric infectious diseases, 1997, Volume: 13 Topics: Adrenal Cortex Hormones; Animals; Antibodies, Monoclonal; Antiviral Agents; Bronchiolitis, Viral; Bronchodilator Agents; Bronchopulmonary Dysplasia; Cost-Benefit Analysis; Disease Models, Animal; Heart Defects, Congenital; Humans; Immunization, Passive; Immunocompromised Host; Infant; Infant, Newborn; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin; Vaccination	1997

Article

Year

Prevention and treatment of respiratory syncytial virus infections (for advances in pediatric infectious diseases).

Advances in pediatric infectious diseases, 1997, Volume: 13

Topics: Adrenal Cortex Hormones; Animals; Antibodies, Monoclonal; Antiviral Agents; Bronchiolitis, Viral; Bronchodilator Agents; Bronchopulmonary Dysplasia; Cost-Benefit Analysis; Disease Models, Animal; Heart Defects, Congenital; Humans; Immunization, Passive; Immunocompromised Host; Infant; Infant, Newborn; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin; Vaccination

1997

Trials

5 trial(s) available for ribavirin and Heart Defects, Congenital

Article	Year
Ribavirin for respiratory syncytial virus bronchiolitis reduced the risk of asthma and allergen sensitization. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2008, Volume: 19, Issue:2 Topics: Antiviral Agents; Asthma; Bronchiolitis, Viral; Child; Child, Preschool; Chronic Disease; Cohort Studies; Female; Follow-Up Studies; Heart Defects, Congenital; Humans; Hypersensitivity; Infant; Lung Diseases; Male; Respiratory Syncytial Virus Infections; Ribavirin; Risk; Risk Factors; Taiwan; Time	2008
Early ribavirin treatment of respiratory syncytial viral infection in high-risk children. The Journal of pediatrics, 1990, Volume: 117, Issue:5 Topics: Bronchopulmonary Dysplasia; Child, Preschool; Double-Blind Method; Female; Heart Defects, Congenital; Humans; Infant; Infant, Newborn; Male; Oximetry; Prospective Studies; Respiration; Respiratory Syncytial Viruses; Respirovirus Infections; Ribavirin; Time Factors	1990
Clinical studies with ribavirin. The Pediatric infectious disease journal, 1990, Volume: 9, Issue:9 Suppl Topics: Bronchopulmonary Dysplasia; Child, Preschool; Combined Modality Therapy; Double-Blind Method; Female; Heart Defects, Congenital; Humans; Infant; Infant, Newborn; Male; Oxygen Inhalation Therapy; Prospective Studies; Respiration, Artificial; Respiratory Syncytial Viruses; Respiratory Tract Infections; Respirovirus Infections; Ribavirin; Risk Factors	1990
Early ribavirin aerosol treatment of respiratory syncytial virus infection in high-risk children. The Pediatric infectious disease journal, 1990, Volume: 9, Issue:9 Suppl Topics: Aerosols; Bronchiolitis, Viral; Bronchopulmonary Dysplasia; Child, Preschool; Female; Heart Defects, Congenital; Humans; Infant; Infant, Newborn; Male; Pneumonia, Viral; Prospective Studies; Respiratory Syncytial Viruses; Respirovirus Infections; Ribavirin	1990
Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. JAMA, 1985, Dec-06, Volume: 254, Issue:21 Topics: Bronchopulmonary Dysplasia; Clinical Trials as Topic; Double-Blind Method; Heart Defects, Congenital; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Oxygen; Random Allocation; Respiratory Syncytial Viruses; Respiratory Tract Infections; Respirovirus Infections; Ribavirin; Ribonucleosides	1985

Other Studies

6 other study(ies) available for ribavirin and Heart Defects, Congenital

Article	Year
Inhibition of cardiomyocyte differentiation of human induced pluripotent stem cells by Ribavirin: Implication for its cardiac developmental toxicity. Toxicology, 2020, 04-15, Volume: 435 Topics: Antiviral Agents; Cell Differentiation; Cell Line; Cell Proliferation; DNA Damage; Dose-Response Relationship, Drug; Gene Expression Regulation, Developmental; Heart Defects, Congenital; Histones; Humans; Induced Pluripotent Stem Cells; Myocytes, Cardiac; Reactive Oxygen Species; Ribavirin; Risk Assessment; RNA, Long Noncoding; Tumor Suppressor Protein p53	2020
Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: a recent experience. Critical care medicine, 1992, Volume: 20, Issue:10 Topics: Academic Medical Centers; Cohort Studies; Heart Defects, Congenital; Hospitals, Pediatric; Humans; Hypertension, Pulmonary; Infant; Infant Mortality; Length of Stay; Michigan; Outcome Assessment, Health Care; Prognosis; Respiration, Artificial; Respiratory Syncytial Viruses; Respirovirus Infections; Retrospective Studies; Ribavirin; Risk Factors	1992
Intensive care course and outcome of patients infected with respiratory syncytial virus. Pediatric pulmonology, 1992, Volume: 13, Issue:3 Topics: Adolescent; Bronchopulmonary Dysplasia; Child; Child, Preschool; Critical Care; Female; Heart Defects, Congenital; Humans; Immunocompromised Host; Infant; Infant, Newborn; Lung; Male; Radiography; Respiration, Artificial; Respiratory Syncytial Viruses; Respirovirus Infections; Retrospective Studies; Ribavirin; Risk Factors; Treatment Outcome	1992
Respiratory syncytial virus infections at Rhode Island Hospital: use of ribavirin. Rhode Island medical journal, 1991, Volume: 74, Issue:1 Topics: Bronchopulmonary Dysplasia; Heart Defects, Congenital; Humans; Infant; Infant, Newborn; Infant, Premature; Prognosis; Respiratory Syncytial Viruses; Respirovirus Infections; Retrospective Studies; Rhode Island; Ribavirin; Seasons	1991
Hemodynamic alterations in patients treated with ribavirin. The Pediatric infectious disease journal, 1990, Volume: 9, Issue:9 Suppl Topics: Bronchiolitis, Viral; Female; Heart Defects, Congenital; Hemodynamics; Humans; Infant; Pneumonia, Viral; Respiratory Syncytial Viruses; Respirovirus Infections; Ribavirin	1990
Refractory congestive heart failure after ribavirin in infants with heart disease and respiratory syncytial virus. The Nebraska medical journal, 1990, Volume: 75, Issue:2 Topics: Heart Defects, Congenital; Heart Failure; Heart Septal Defects; Humans; Infant; Infant, Newborn; Respiratory Syncytial Viruses; Respirovirus Infections; Ribavirin; Ribonucleosides	1990